Newell Clifford Doyle III
Known title: VP of Corporate DevelopmentCIK: 0001956712
Associated companies
Transaction History
| CRK | ▼ Sell | Tax Withholding | 2,651 | $34K | 6/6/2026 | View on chart |
| CRK | ▼ Sell | Tax Withholding | 3,591 | $71K | 2/19/2026 | View on chart |
| CRK | ▼ Sell | Tax Withholding | 2,496 | $48K | 2/12/2026 | View on chart |
| CRK | ▲ Buy | Grant | 32,776 | $736K | 1/27/2026 | View on chart |
| CRK | ▼ Sell | Tax Withholding | 1,234 | $31K | 6/14/2025 | View on chart |
| CRK | ▲ Buy | Option Exercise | 19,448 | $0 | 6/14/2025 | View on chart |
| CRK | ▼ Sell | Tax Withholding | 7,652 | $194K | 6/14/2025 | View on chart |
| CRK | ▼ Sell | Tax Withholding | 2,649 | $65K | 6/6/2025 | View on chart |
| CRK | ▼ Sell | Tax Withholding | 3,886 | $81K | 2/19/2025 | View on chart |
| CRK | ▲ Buy | Grant | 26,545 | $0 | 2/12/2025 | View on chart |
| CRK | ▼ Sell | Tax Withholding | 1,527 | $17K | 6/14/2024 | View on chart |
| CRK | ▼ Sell | Tax Withholding | 1,639 | $19K | 6/6/2024 | View on chart |
| CRK | ▲ Buy | Grant | 44,233 | $0 | 2/19/2024 | View on chart |
| CRK | ▲ Buy | Grant | 20,204 | $0 | 6/6/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Mizuho and Morgan Stanley Lower CRK Price Targets
Mizuho and Morgan Stanley recently lowered their price targets for Comstock Resources, setting them at $17 and $13 respectively. Both firms maintained their neutral and equal-weight ratings, suggesting a cautious outlook on the stock. These adjustments place the targets within the broader analyst range of $13 to $20, reflecting mixed sentiment on the company's near-term prospects.
Mizuho and Morgan Stanley Lower CRK Price Targets. Mizuho and Morgan Stanley recently lowered their price targets for Comstock Resources, setting them at $17 and $13 respectively. Both firms maintained their neutral and equal-weight ratings, suggesting a cautious outlook on the stock. These adjustments place the targets within the broader analyst range of $13 to $20, reflecting mixed sentiment on the company's near-term prospects.